A Century of Milestones and Breakthroughs Related to Low- and High-Density Lipoproteins

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2023 Dec 27

PMID 38150515

Authors

Mary G Sorci-Thomas

Robert A Hegele

Alan T Remaley

Affiliations

Soon will be listed here.

References

Segrest J, Jackson R, Morrisett J, Gotto Jr A . A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett. 1974; 38(3):247-58. DOI: 10.1016/0014-5793(74)80064-5. View

von Eckardstein A, Nordestgaard B, Remaley A, Catapano A . High-density lipoprotein revisited: biological functions and clinical relevance. Eur Heart J. 2022; 44(16):1394-1407. PMC: 10119031. DOI: 10.1093/eurheartj/ehac605. View

Rubin E, Krauss R, Spangler E, Verstuyft J, Clift S . Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991; 353(6341):265-7. DOI: 10.1038/353265a0. View

Sposito A, Carmo H, Barreto J, Sun L, Carvalho L, Feinstein S . HDL-Targeted Therapies During Myocardial Infarction. Cardiovasc Drugs Ther. 2019; 33(3):371-381. DOI: 10.1007/s10557-019-06865-1. View

Wilhelm A, Zabalawi M, Owen J, Shah D, Grayson J, Major A . Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem. 2010; 285(46):36158-69. PMC: 2975238. DOI: 10.1074/jbc.M110.134130. View

Fredrickson D, Levy R, Lees R . Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967; 276(5):273-81 concl. DOI: 10.1056/NEJM196702022760507. View

Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W . The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999; 22(4):347-51. DOI: 10.1038/11914. View

Brooks-Wilson A, Marcil M, Clee S, Zhang L, Roomp K, Van Dam M . Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999; 22(4):336-45. DOI: 10.1038/11905. View

Glomset J, JANSSEN E, Kennedy R, Dobbins J . Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins. J Lipid Res. 1966; 7(5):638-48. View

10.

Endo A . The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992; 33(11):1569-82. View

11.

Rust S, ROSIER M, Funke H, Real J, Amoura Z, Piette J . Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999; 22(4):352-5. DOI: 10.1038/11921. View

12.

Boren J, Chapman M, Krauss R, Packard C, Bentzon J, Binder C . Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313-2330. PMC: 7308544. DOI: 10.1093/eurheartj/ehz962. View

13.

Seidah N, Awan Z, Chretien M, Mbikay M . PCSK9: a key modulator of cardiovascular health. Circ Res. 2014; 114(6):1022-36. DOI: 10.1161/CIRCRESAHA.114.301621. View

14.

Han Y, Onufer E, Huang L, Sprung R, Davidson W, Czepielewski R . Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science. 2021; 373(6553). PMC: 8478306. DOI: 10.1126/science.abe6729. View

15.

Khera A, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke M, Jafri K . Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364(2):127-35. PMC: 3030449. DOI: 10.1056/NEJMoa1001689. View

16.

Siri-Tarino P, Krauss R . The early years of lipoprotein research: from discovery to clinical application. J Lipid Res. 2016; 57(10):1771-1777. PMC: 5036374. DOI: 10.1194/jlr.R069575. View

17.

Acton S, Scherer P, Lodish H, Krieger M . Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem. 1994; 269(33):21003-9. View

18.

Goldstein J, Brown M . The LDL receptor. Arterioscler Thromb Vasc Biol. 2009; 29(4):431-8. PMC: 2740366. DOI: 10.1161/ATVBAHA.108.179564. View

19.

Gofman J, Delalla O, Glazier F, Freeman N, Lindgren F, Nichols A . The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease. J Clin Lipidol. 2011; 1(2):104-41. DOI: 10.1016/j.jacl.2007.03.001. View